Bruceoside A ( —— )

产品货号. M31791 CAS No. 63306-30-9

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Bruceoside A
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
产品描述

Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. It significantly inhibited P-388 lymphocytic leukemic cell RNA and protein synthesis in tissue culture.
体外实验

——
体内实验

Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. Animal Model:Male ICR mice weighing 25.0 ± 5.0 g.Dosage:22.5 mg/kg.Administration:Intragastrically administrated.Result:Reached its highest levels in three hours with a half-life value of 3.99 h.
同义词

——
通路

Others
靶点

Other Targets
受体

——
研究领域

——
适应症

——

计算器

产品手册

关联产品

(Z)-1-Methyl-2-(unde...

(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one shows strong inhibitory activity on leukotriene biosynthesis in human polymorphonuclear granulocytes, and it is very effective against mycobacteria.
FIDAS-5

FIDAS-5 有效地与 S-腺苷甲硫氨酸 (SAM) 竞争 MAT2A 结合。 FIDAS-5 具有抗癌活性。 FIDAS-5 是一种有效的口服活性蛋氨酸 S-腺苷转移酶 2A (MAT2A) 抑制剂，IC50 为 2.1 μM。FIDAS-5 诱导细胞周期抑制剂 p21WAF1/CIP1 的表达。 FIDAS-5（3 μM；36 小时）处理可降低 LS174T 细胞中 S-腺苷甲硫氨酸（SAM）和 S-腺苷高半胱氨酸（SAH）的水平。FIDAS-5（3 μM；7 天；LS174T 细胞）处理显着抑制LS174T细胞的增殖。
N-Acetyl-O-phosphono...

Phosphopeptide; binds to the src SH2 domain.